|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: LINC01725 |
Gene summary for LINC01725 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | LINC01725 | Gene ID | 101927587 |
| Gene name | long intergenic non-protein coding RNA 1725 | |
| Gene Alias | LINC01725 | |
| Cytomap | 1p31.1 | |
| Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 101927587 | LINC01725 | NAFLD1 | Human | Liver | NAFLD | 3.11e-17 | 1.22e+00 | -0.04 |
| 101927587 | LINC01725 | S41 | Human | Liver | Cirrhotic | 1.75e-03 | 6.40e-01 | -0.0343 |
| 101927587 | LINC01725 | HCC1_Meng | Human | Liver | HCC | 4.93e-06 | -1.85e-01 | 0.0246 |
| 101927587 | LINC01725 | HCC2_Meng | Human | Liver | HCC | 1.02e-04 | -1.85e-01 | 0.0107 |
| 101927587 | LINC01725 | cirrhotic1 | Human | Liver | Cirrhotic | 1.05e-05 | -1.85e-01 | 0.0202 |
| 101927587 | LINC01725 | cirrhotic2 | Human | Liver | Cirrhotic | 1.05e-05 | -1.85e-01 | 0.0201 |
| 101927587 | LINC01725 | cirrhotic3 | Human | Liver | Cirrhotic | 2.78e-03 | -1.85e-01 | 0.0215 |
| 101927587 | LINC01725 | Pt13.a | Human | Liver | HCC | 4.93e-06 | -1.85e-01 | 0.021 |
| 101927587 | LINC01725 | Pt13.b | Human | Liver | HCC | 1.85e-02 | -1.85e-01 | 0.0251 |
| 101927587 | LINC01725 | Pt14.d | Human | Liver | HCC | 4.93e-06 | -1.85e-01 | 0.0143 |
| 101927587 | LINC01725 | S016 | Human | Liver | HCC | 1.56e-02 | -1.85e-01 | 0.2243 |
| 101927587 | LINC01725 | HTA12-25-1 | Human | Pancreas | PDAC | 3.20e-04 | 5.34e-01 | 0.313 |
| 101927587 | LINC01725 | HTA12-26-1 | Human | Pancreas | PDAC | 1.18e-05 | 3.69e-01 | 0.3728 |
| 101927587 | LINC01725 | HTA12-29-1 | Human | Pancreas | PDAC | 5.37e-27 | 7.48e-01 | 0.3722 |
| Page: 1 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| Page: 1 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |